Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
BCC Research LLC has raised $43 million in Series B funding to advance AI-driven dermatology devices, enhancing diagnostic accuracy with 96% sensitivity in melanoma detection.
PRIVATEJun 17, 2026•about 2 months ago
Amount Raised
$43 Million
Round Type
Series B
BostonBiotechnologyLife Science
Description
BCC Research's new report highlights the transformative role of AI in dermatology. Breakthrough algorithms achieve 96% sensitivity in melanoma detection while minimizing wait times and unnecessary surgeries. The funding aims to further develop AI technologies that optimize therapeutic outcomes. Key market players include DermaSensor Inc
Company Information
Company
BCC Research
Location
Boston, Massachusetts, United States
About
BCC Research is a Boston-based market research firm with strengths in the life sciences. They provide objective, unbiased measurement and assessment of market opportunities through detailed market research reports. With over 50 years of experience, they have a strong foundation in driving future businesses and markets.
Related People
Suggested for you
1 contact
Verified contactsBob K., Senior Director, Global Accounts
Predictive Intelligence
Strategic
ML-powered predictions for BCC Research's next move